T1D Exchange at the 85th Scientific Sessions

Visit us in the exhibit hall throughout the conference to learn more about our presentations, quality improvement initiatives, custom research offerings, study recruitment services, and more! 

T1D Exchange Booth: #1145

Saturday, June 21 

12:30-1:30 PM | Poster Session | Poster Hall (Hall F1) 

• 1002-P: HbA1c Improvement with the Addition of Continuous Glucose Monitoring to GLP-1 Agonist Therapy in People with Type 2 Diabetes 
  • Presented by: Susan Thapa, PhD, MPH 

Sunday, June 22 

12:30-1:30 PM | Poster Session | Poster Hall (Hall F1) 

• 1139-P: Assessing Clinic Readiness for Implementation of Equitable and Sustainable New-Onset Care in the T1DX-QI 
  • Presented by: Franziska K. Bishop, MS, CDCES, Stanford University 

• 1900-LB: Inpatient Education and Discharge Support in the T1D Exchange Quality Improvement Collaborative (T1DX-QI) 
  • Presented by: Grenye O’Malley, MD, Icahn School of Medicine at Mount Sinai 

• 1933-LB: Assessing the Financial Strain of Diabetes-Related Costs in Adults with Type 1 Diabetes 
  • Presented by: Megan Peter, PhD, T1D Exchange 

• 1937-LB: Exploring Associations between Duration of Type 1 Diabetes and Experiences with Anxiety and Depression among Adults in the T1D Exchange Registry 
  • Presented by: Emilee M. Cornelius, MPH, BS, T1D Exchange 

• 1942-LB: Diabetes Distress Screening in Type 1 Diabetes: Are We Meeting Standards in Psychosocial Care?  
  • Presented by: Jennifer Iyengar, MD, University of Michigan 

• 1955-LB: Experiences and Preferences for Mental Health Support with Diabetes Health Care Providers among Adults in the T1D Exchange Registry 
  • Presented by: Katherine S.M. Chapman, MS, T1D Exchange 

• 2053-LB: Racial/Ethnic Distribution of People with Diabetes and Diabetes Center Staff— 2024 T1D Exchange Quality Improvement Collaborative (T1DX-QI) Survey Results 
  • Presented by: Dhruvi Vora, T1D Exchange 

• 2073-LB: Teamwork, Targets, Technology, and Tight Range (4T) in New-Onset T1D— Comparing Outcomes and Rationale for Translation 
  • Presented by: Saketh Rompicherla, MS, T1D Exchange 

• 2105-LB: Limited Readiness for Type 1 Diabetes (T1D) Autoantibody Screening and Metabolic Monitoring among Pediatric and Adult Diabetes Centers in the T1DXQuality Improvement Collaborative (T1DX-QI)
  • Presented by: Laura M. Jacobsen, MD, University of Florida 

• 2119-LB: Lifetime Prevalence and Cumulative Burden of Musculoskeletal Conditions in the Type 1 Diabetes Exchange Registry 
  • Presented by: Jaime Lucove, MSPH, T1D Exchange 

4:00-4:15 PM | Adaptation of Diabetes Technologies | Room W185 A-D  

• 276-OR: T1D Exchange Multicenter Study—Increasing CGM Adoption in Type 2 Diabetes 
  • Presented by: Ori Odugbesan, MD, MPH, T1D Exchange 

Monday, June 23 

12:30-1:30 p.m. | Poster Session | Poster Hall (Hall F1) 

• 1218-P: Benchmarking Ratio of Diabetes Providers to Number of People with Type 1 Diabetes across Nine Pediatric Centers 
  • Presented by: Nicole Rioles, MA, T1D Exchange